Informed Consent and Adverse events [GxP / QC / QA]

posted by drgunasakaran1  – 2012-10-09 22:24 (4995 d 18:22 ago) – Posting: # 9366
Views: 5,738

Dear Mr Yogesh,

❝ Is it is also necessary to document the adverse events reported for that molecule as mentioned in the label in Protocol and Informed consent form?


Yes. It is mandatory to document all the adverse events reported in the SmPC/Prescribing Information in the Informed Consent Document.

❝ Or is it is sufficient to write the adverse events observed with out the study details and percentages.


No. Will not be accepted by the Regulatory Authorities.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
137 visitors (0 registered, 137 guests [including 25 identified bots]).
Forum time: 16:46 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5